Breaking News
Global News
Chola Securities in News
Sessions News
Economy News
Nifty 50
Sensex
Nifty Bank
Bankex
Nifty 100
BSE Sensex 50
Nifty Financial Services
BSE Sensex Next 50
Nifty Midcap 100
BSE Bharat 22
DJIA
S&P 500
Hang Seng
Nikkei 225
FTSE 100
Exchange Holiday List
Historical Returns
Top Gainers
Top Losers
52 Week High
52 Week Low
Most Active by Value
Most Active by Volume
Out Performer
Under Performer
Advances & Declines
Only Buyers and Sellers
Bulk deal
Block deal
Nifty Futures
Nifty Options
Bank Nifty Futures
Bank Nifty Options
Stock Futures
Stock Options
Increase in OI
Decrease in OI
Highest in OI
Lowest in OI
All Index Futures
Most Active Contracts
Most Active Call
Most Active Put
Solutions
Platforms
Research
Investments
Become a partner
More
Markets
Abbott India Limited will hold a board meeting on Thursday, November 5, 2026, to consider and approve the unaudited financial results for the second quarter and half year ended September 30, 2026, according to a regulatory filing with the BSE Limited. The company’s trading window will remain closed from Thursday, October 1, 2026, to Saturday, November 7, 2026, in accordance with insider trading regulations.
Aditya Vision Limited will hold a board meeting on Friday, October 30, 2026, to consider and approve the standalone unaudited financial results for the quarter and half year ended September 30, 2026, in compliance with Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the trading window for dealing in the company's securities has been closed from October 1, 2026, and will remain closed until 48 hours after the results are made public.
Adon Agro Commodities Limited will hold a board meeting on Tuesday, November 3, 2026, to consider and approve the unaudited financial results (standalone and consolidated) for the half year ended September 30, 2026, according to a filing with the BSE Limited. The trading window for the company's securities will remain closed for designated persons and their immediate relatives from October 1, 2026, until 48 hours after the unaudited financial results are declared to the stock exchanges.
Advance Technoforge Limited will hold a board meeting on Thursday, November 05, 2026, to approve its standalone unaudited financial results for the half year ended September 30, 2026, according to a regulatory filing. The company also stated that the trading window for its securities will be closed from October 1, 2026, until 48 hours after the financial results are declared.
Aequs Limited’s Nomination and Remuneration Committee approved the grant of 2,00,000 employee stock options under the Aequs Employee Stock Option Plan 2025 to an eligible employee, according to a regulatory filing with the National Stock Exchange of India Limited and BSE Limited on October 26, 2026. The exercise price for the options is Rs 235.50 per stock option, and the options will vest over a minimum period of one year, with a three-year exercise window following vesting.
Aimco Pesticides Limited will hold a meeting of its Board of Directors on November 5, 2026, to consider and approve the un-audited financial results (standalone & consolidated) along with the Limited Review Reports of the Statutory Auditor for the second quarter and half year ended September 30, 2026, of the financial year 2026-27.
Alchemist Corporation Limited will hold a board meeting on Thursday, October 29, 2026, to consider and approve the unaudited standalone and consolidated financial results for the second quarter ended September 30, 2026, according to a regulatory filing with the BSE Limited. The company’s trading window for insiders remains closed from October 1, 2026, until 48 hours after the financial results are declared.
Alldigi Tech Limited will consider a proposal for the buyback of its fully paid up equity shares at a meeting of its Board of Directors scheduled for Thursday, October 29, 2026, according to a regulatory filing with the BSE Limited and National Stock Exchange of India Limited.
Alphalogic Industries Limited has received Rs 69,30,000 from Vivaro Enterprises Limited on September 29, 2026, as part of a larger allotment of 3,30,000 fully paid-up equity shares, representing 75% of the warrant issue price, with an aggregate amount of Rs 92,40,000 including an earlier receipt of Rs 23,10,000, according to a filing with the BSE Limited. The company secretary and compliance officer, Aayushi Khandelwal, submitted the statement of fund utilization and deviation, noting no deviation in the use of the raised funds, which were intended for working capital requirements, general corporate purposes, and issue expenses.
Amanta Healthcare Limited will hold a board meeting on Tuesday, November 3, 2026, to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2026, the company said in a filing with the BSE Limited and National Stock Exchange of India Limited. The trading window, previously closed from October 1, 2026, will reopen on November 6, 2026, in compliance with SEBI regulations.
SEBI presents Samajh Se Investing Simple:
SEBI प्रस्तुत करता है – समझ से निवेश आसान: